Syndax Pharmaceuticals (SNDX) Reports Q2 Loss of $0.47/Share

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q2 EPS of ($0.47), versus ($440.52) reported last year. Revenue for the quarter came in at $305 thousand, versus $17 thousand reported last year.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance